Glial cell line-derived neurotrophic factor (GDNF) is
INTRODUCTION
Glial cell line-derived neurotrophic factor (GDNF), a distant member of the transforming growth factor β (TGF-β) superfamily, was discovered as a potent survival factor for central dopaminergic neurons (1) . As a neurotrophic factor, GDNF is expressed in the developing central nervous system but it is also found in many peripheral tissues including embryonic kidney, gastrointestinal tract and skeletal muscle (2, 3) . GDNF and the genes responsible for its signal transduction are of great clinical interest due to their potential use in therapy for motoneuron and Parkinson's diseases. In addition, these genes are intensively studied as possible candidate disease genes for congenital or inherited disorders affecting the survival of the neurons in substantia nigra and in the gastrointestinal tract.
Unlike the other TGF-β family growth factors that signal through serine-threonine kinase receptors, signal of GDNF is mediated by a complex of the receptor tyrosine kinase Ret (4, 5) and a glycosyl-phosphatidylinositol (GPI) linked protein, GDNF receptor-α, GDNFR-α (6,7). Murine mRNA for this 468 amino acid long protein is expressed in a variety of neuronal and non-neuronal embryonic tissues including ventral midbrain, ventral spinal cord, kidney and enteric nervous system (7) . The locus for human GDNF gene is in chromosome 5p12-p13.1 (8) , but the chromosomal localisation of GDNFR-α in human or mouse has not been reported. The gene encoding Ret has been assigned to human chromosome 10q11.2 (9) and mutations or translocations constitutively activating the receptor lead to the multiple endocrine neoplasia MEN 2 syndrome with sybtypes of 2A and 2B (10) . Inactivating germline mutations in the Ret gene are known to cause 30-50% of Hirschsprung's disease (aganglionotic megacolon) (11) . GDNF-and RET-null mutant mice also share the closely similar phenotype of disturbed gut innervation and kidney agenesis (12) (13) (14) . Although some GDNF mutations have been reported in Hirschsprung's disease patients (15, 16) , they do not seem to be alone sufficient to cause Hirschsprung's disease; however, biochemical data on these mutations have not been published. Neither disease mutations in GDNFR-α gene nor the knock-out mouse phenotype have been published. A close GDNF homologue, neurturin, has recently been characterised (17) and another one, persefin, is known (18), but its biochemical properties have not yet been described. At present, there is no evidence how either one of these homologues interact with GDNF receptors. *To whom correspondence should be addressed. Tel: +358 9 708 59395; Fax: +358 9 708 59366; Email: petro.suvanto@helsinki.fi The alignment of the predicted human and rat GDNFR-β and GDNFR-α proteins (6) with MAP multiple alignment program (34) . The putative signal sequence is predicted according to von Heijne (35) , N-glycosylation sites are underlined and amino acid residues identical in at least three out of the four sequences are marked bold.
Here we have characterised the cDNA, tissue distribution and chromosomal localisation of a new gene termed GDNF receptor β (GDNFR-β), which is highly homologous to GDNFR-α. We also show that it participates in GDNF-signalling by mediating GDNF-induced autophosphorylation of Ret.
RESULTS
Rat GDNFR-α sequence (6, GenBank accession number U59486) was used to screen the human EST database and eight human sequences from six different clones (GenBank accession numbers H12981, H05619, R02135, R02249, T03342, W73681, W73633 and Z43761) with high similarity (identity >70% over 200 bp) were identified. Full sequence analysis of three EST clones revealed 3′-terminal consensus sequence named human EST GDNFR-β cDNA (nucleotides 469-1490 in Fig. 1A) . To obtain complete cDNA, human EST GDNFR-β cDNA was used for screening adult rat hippocampus cDNA library. Two identical clones out of one million contained 2002 bp long sequence with 91% identity to probe. Rat cDNA sequence for GDNFR-β (GenBank accession number AF003825) lacked ∼60 3′-terminal nucleotides of the open reading frame judged from human EST GDNFR-β and GDNFR-α. With a forward primer designed from rat GDNFR-β sequence, 5′ end of human GDNFR-β was amplified by PCR from human total brain cDNA. The human GDNFR-β cDNA sequence (GenBank accession number U93703) contains a 1395 bp long open reading frame (Fig. 1A) . At amino acid level, human and rat GDNFR-β orthologues were 96% identical. The predicted 47 kDa (unglycosylated) mature protein consists of 464 amino acids that are 48% identical and up to 63% similar to the published sequence of human and rat GDNFR-α proteins (6) (Fig. 1B) . The amino acid sequence of GDNFR-β has a putative signal sequence, three N-glycosylation sites, and a putative GPI-anchor site similar to GDNFR-α. Completely conserved cysteine residues and strong overall resemblance to GDNFR-α predict high similarity in the spatial structures of the GDNF-receptors α and β (Fig. 1B) .
The tissue distribution of human GDNFR-β was studied by northern hybridisation of mRNA extracted from different adult and fetal tissues. The expression of GDNFR-β mRNA was abundant in adult brain, intestine and placenta, as well as in fetal brain, lung and kidney. Two major transcripts of 2.9 and 3.5 kb were visible in all these tissues, and additional transcripts of 7.5 kb in placenta and 1.4 kb in testis ( Fig. 2) were found.
The chromosomal locus of GDNFR-β was assigned to human chromosome 8p21-22 by fluorescent in situ hybridisation (FISH) with the 1.49 kb human GDNFR-β cDNA probe. In addition, the locus for mouse GDNFR-β gene was assigned to the mouse chromosome 14D3-E1 that corresponds to the human locus 8p21-22 (Fig. 3) .
The hallmark of a growth factor-induced signal transduction through receptor tyrosine kinases is phosphorylation of the tyrosine residues of the receptor upon ligand binding (19) . To study whether GDNFR-β can mediate GDNF-induced activation of Ret receptor tyrosine kinase, COS-7 cells were transiently transfected with cDNAs encoding GDNF receptors in different combinations and treated with GDNF. The state of Ret phosphorylation was analysed by western blotting with anti-phosphotyrosine antibodies. GDNF (100 ng/ml) induced phosphorylation of the 170 kDa form of Ret only in the presence of either GDNFR-α or GDNFR-β (Fig. 4) , but not without these receptors. The 170 kDa form of Ret represents the fully glycosylated mature receptor on the plasma membrane (20) . In control cells co-transfected with GDNFR-α and GDNFR-β but without Ret, no tyrosine phosphorylated proteins were precipitated by anti-Ret antibodies (Fig. 4) . Identical results were gained when a GDNFR-β construct lacking GPI-anchor was used (data not shown).
The mRNA expression patterns of GDNFR-α and GDNFR-β mRNAs were compared in E17 rat embryo by in situ hybridisation. In several organs, GDNFR-α and GDNFR-β mRNAs showed distinct, non-overlapping distributions. Strong GDNFR-β mRNA expression was seen in the capsule and cortex of adrenal gland (Fig. 5A and B) , whereas GDNFR-α mRNA was detected in adrenal medulla (Fig. 5A and C) . In kidney, GDNFR-α transcripts were seen in the tips of ureter bud, condensed mesenchyme and early epithelial tubules (Fig. 5D  and F) , whereas GDNFR-β mRNA was present in undifferentiated nephrogenic mesenchyme and in the muscle wall of renal pelvis (Fig 5D and E) . Strong expression of GDNFR-α mRNA was present in the muscle and nervous layers along gastrointestinal tract (Fig. 5G and I) . In stomach, GDNFR-β mRNA was moderately expressed in nervous layers (not shown), while in enteric plexus of small intestine only low amounts of transcripts were detected ( Fig. 5G and H) .
In embryonic (E)17 rat nervous system, GDNFR-α mRNA was abundantly expressed in spinal cord, especially in ventral motoneurons (Fig. 5J and L) . Also GDNFR-β mRNA was present in many areas of spinal cord including ventral motoneurons ( Fig.  5J and K) , though the levels were moderate. In dorsal root and trigeminal ganglia, GDNFR-β mRNA expression was restricted to subpopulations of neuronal cells (Fig. 5J , K, M and N), resembling Ret mRNA distribution (21) . In contrast, varying amounts of GDNFR-α transcripts could be detected throughout the ganglia (Fig. 5J , L, M and O) and also in the cells covering trigeminal and spinal nerves ( Fig. 5M and O) , suggesting expression in both neuronal and glial cells.
DISCUSSION
We have characterised the human and rat cDNA sequences of a new GDNF signal mediating receptor and shown its mRNA expression in multiple adult and fetal tissues that are known to express GDNF and the GDNF receptor tyrosine kinase Ret. Similarly to the earlier characterised GDNF-binding protein, GDNFR-α (6,7), GDNFR-β participates in the GDNF-induced autophosphorylation of Ret receptor tyrosine kinase. Unique mRNA expression pattern during embryonic development in several organs including adrenal gland, kidney and gut as well as in nervous system, suggests a functionally independent role for GDNFR-β.
Cytokine and growth factor receptors are usually quite complex allowing much redundancy in the choice of ligands and signalling molecules. Of neurotrophic factors, in the neurotrophin (NT) family (22, 23) , one of the ligands, NT-3, can activate all three Trk tyrosine kinase receptors, while one of the receptors, TrkB, is a high-affinity receptor for at least two neurotrophins. Additionally, neurotrophins signal through low-affinity neurotrophin receptor p75. In the case of cytokines ciliary neuronotrophic factor (CNTF) and leukemia inhibitory factor (LIF), the picture is even more perplexing (23) . CNTF and LIF use the same receptor molecules (gp130/LIFR-β), but in addition, CNTF needs a non-signalling partner (CNTFR-α) to form a complex with gp130, which is a receptor tyrosine kinase also transducing signals of IL-6 and oncostatin M.
GDNFR-α and GDNFR-β resemble non-signalling components of CNTF/LIF receptors, since they lack apparent signal transducing properties (25) . Thus, the GDNF induced activation of signalling receptor Ret is mediated by at least two non-signalling receptors. Simultaneous presence of two similarly behaving GDNF-presenting proteins may lower the amount of GDNF needed to activate Ret. At least for spinal motoneurons, which contain mRNAs for all three GDNF receptors, very low concentrations (15 fM) of GDNF are needed for survival (26) . In accordance, mRNA levels of GDNF in skeletal muscles are quite low (2) . On the other hand, in the ureter buds of developing kidney, only GDNFR-α is present with Ret and GDNF mRNA levels being extremely high. The fact that GDNFR-β mRNA is present in some organs (such as adrenal cortex) where GDNF is not available points to the possibility that some other ligand (such as the GDNF homologues neurturin and persefin) may use GDNFR-β in their signal transduction. Likewise, GDNFR-β may also be used in the activation of signalling receptors other than Ret. The relations between GDNF, its homologues and their receptors remain to be determined.
At present, there is no candidate disease assigned to the human locus for the GDNFR-β gene on 8p21-22, but since it probably participates in the signal transduction of GDNF in neurons, the new receptor GDNFR-β is likely to be of great interest in investigations concerning neurodegenerative diseases. In addition, the gene for GDNFR-β is a potent candidate disease gene for congenital disorders that resemble the phenotypes of GDNF or Ret knock-out mice (e.g. Hirschsprung disease, kidney aplasia and dysplasia) and we are screening for mutations in these developmental disorders.
MATERIALS AND METHODS

GDNFR-β cDNA cloning
The I.M.A.G.E. EST bacteria clones were obtained from UK MRC Human Genome Mapping Project Resource Centre, Cambridge and were amplified by standard methods. Plasmids were purified with Wizard Miniprep purification kit (Promega) and sequenced with the A.L.F. system (Pharmacia). Two of the EST clones (GenBank accession numbers H12981 and R02249) produced identical, 1032 bp long sequences (Fig. 1A) . The third clone (GenBank accession number W73681) contained shorter, but identical sequence over the same area. EST databank sequences of the same clones were partial and contained numerous minor errors (including short deletions), which prevented the determination of the presence of a proper reading frame.
The adult rat hippocampus λ ZAP cDNA library (Stratagene) was plated, blotted to nylon membrane (Amersham), and hybridised with human EST GDNFR-β probe (Fig. 1A) . Two plaques out of one million hybridized to the probe were replated and purified, pBK-plasmids were excised with helper virus, amplified, purified and sequenced with the A.L.F. system (Pharmacia). Human brain total RNA was extracted by standard methods and reverse transcribed in a random-primed reaction as described in Superscript II (Life Technologies) protocol. The human GDNFR-β gene was amplified from cDNA under the following PCR conditions: dNTPs in 200 µM concentration and primers (forward) 5′-ATGATCTTGGCAAACGCCTTCTG-3′ and (reverse) 5′-TTGCAGTTGTCATTCAGGTTGC-3′ in 1 µM concentration, ∼5 ng human brain cDNA, 1 U Dynazyme (Finnzymes) Taq polymerase in 50 µl. The 30 cycles after an initial 5 min at 94_C consisted of 30 s at 94_C, 30 s at 57_C and 1 min at 72_C with a final 5 min extension at 72_C. The PCR fragments were cloned into pGEM-T vector (Promega) and four different clones were sequenced. With several primer pairs complete GDNFR-β cDNA sequence was amplified by PCR from the same human brain cDNA. This sequence was identical to the EST-derived sequence. The overlapping inserts of EST and PCR fragments were combined and cloned to get the contig of the full-length human cDNA.
Human full-length GDNFR-β cDNA was cloned into pCDNA3 (Invitrogen) and pBK-CMV (Stratagene) mammalian expression vectors. Rat GDNFR-β cDNA was cloned into the same expression vectors. In one rat construct, 3′ end of human GDNFR-β cDNA was added using a unique BclI restriction site, and in another construct an artificial stop codon was inserted instead of the GPI-tail, producing an apparently soluble form of rat GDNFR-β.
Northern analysis
For northern hybridisation 100 ng of the human EST GDNFR-β insert was labelled with [ 32 P]dCTP (Amersham) by Prime-a-Gene kit (Promega). The specific activity of the final probe was 2 × 10 7 c.p.m./µg and the hybridisation of Human and Human Fetal Multiple Tissue Northern Blot filters (Clontech) was performed in ExpressHyb solution at 65_C for 2 h. The filters were washed twice for 30 min at 50_C in 2× saline sodium citrate (SSC) + 0.1% SDS and 0.1× SSC + 0.1% SDS and then analysed by phosphoimager (Fuji BAS 1500). As a control, the same filters were hybridised with human β-actin probe (Clontech).
Fluorescent in situ hybridisation
Human peripheral blood lymphocytes were cultured and a cell culture from mouse fetal tissue was established according to standard protocols (26) and used as a source of metaphase chromosomes. Both human lymphocytes and mouse monolayer cells were treated with 5-bromodeoxyuridine at early replicating phase to induce a banding pattern (27, 28) . The slides were stained with Hoechst 33258 (1 µg/ml) and exposed to UV-light (302 nm) for 30 min. The probes were labelled by a nick translation kit (BRL) with biotin-11-dUTP (Sigma) and the FISH procedure was carried out in 50% formamide, 10% dextran sulphate in 2× SSC as described earlier (29, 30) . Repetitive sequences were suppressed with 10-fold excess of Cot-1-DNA (BRL) and after overnight incubation unspecific hybridisation signals were eliminated by washing the slides with 50% formamide/2× SSC, 2× SSC and 0.5× SSC at 45_C. Specific hybridisation signals were visualised using FITC-conjugated avidin (Vector Laboratories) and slides were counterstained with 4′-6′-diamino-2-phenylindole (25 ng/ml). The image analysis for acquisition, display and quantification of hybridisation signals was performed with a PXL camera (Photometrics) attached to a PowerMac 7100/AV workstation. IPLab software controls the camera operation, image acquisition and Ludl wheel (31) . The probe for human GDNFR-β gene was 1490 bp long cDNA and the hybridisation showed specific double spot signal in 30 out of 100 metaphase chromosomes that were identified based on their G-banding pattern. The hybridisation signal of the 10 kb genomic mouse probe showed specific localisation in 27 out of 30 mouse metaphase chromosomes (32) .
Cell transfection and tyrosine phosphorylation assay
COS-7 cells (5 × 10 6 cells per experimental point) were cotransfected by electroporation (Bio-Rad) with cDNAs (5 µg each) of Ret and GDNFR-α, Ret and GDNFR-β, GDNFR-α and GDNFR-β, or with cDNA of Ret alone and cultured for 48 h. Cellular phosphatases were inhibited by 1 mM Na 3 VO 4 for 1 h, the cells were treated with 100 ng/ml of GDNF (Promega or PeproTech Ltd) for 30 min and lysed in Tris-balanced saline, pH 7.5, containing 2 mM EDTA, 10% glycerol, 1% NP-40, 1% Triton X-100 and protease inhibitors. Proteins immunoprecipitated by anti-Ret antibodies (Santa Cruz) were analysed by western blotting with anti-phosphotyrosine antibodies PY20 (Transduction Laboratories). In experiments with the secreted form of GDNFR-β lacking a GPI anchor, the cells were not washed before GDNF treatment.
In situ hybridization
In situ hybridization on E17 rat sections was performed exactly as described previously (2, 33) . The antisense cRNA probes for rat GDNFR-α and rat GDNFR-β covered nucleotides 294-1039 of GenBank sequence U59486 and nucleotides 1231-1394 of GenBank sequence (AF003825), respectively.
